Clinical Study Results
It was planned that the same participants would be in all 3 parts. But, there were 4
participants who left the study before it ended.
The chart below shows the treatments the participants took.
Part 1 Part 2 Part 3
(20 participants) (18 participants) (16 participants)
What study treatment • All of the participants • All of the participants • All of the participants
did the participants took savolitinib as a took rifampicin as a took savolitinib and
take? pill by mouth pill by mouth rifampicin as a pill by
mouth
How often did the • Once • Once a day for 5 days The participants took:
participants take study
• savolitinib and
treatment?
rifampicin on the
first day
• rifampicin only on the
second day
What happened during the study?
The study started in October 2019 and ended in February 2020.
Before the participants took treatment, they visited their study site 1 time over the
course of about 1 month. During this visit, the study doctors checked to make sure the
participants could join the study. The study doctors:
• did a physical examination
• took blood and urine samples
• checked the participants’ heart health using an electrocardiogram, also called an
ECG
• asked the participants about their medical history, how they were feeling, and what
medicines they were taking
3